Literature DB >> 6788362

Sensitization of 9L rat brain gliosarcoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.

D T Hung, D F Deen, J Seidenfeld, L J Marton.   

Abstract

alpha-Difluoromethylornithine, a known inhibitor of polyamine biosynthesis, significantly enhanced the cytotoxic effect of 1,3-bis(2-chloroethyl)-1-nitrosourea, a cell cycle-nonspecific agent, in 9L rat brain gliosarcoma cells in vitro. Administered as a single agent, alpha-difluoromethylornithine was not cytotoxic to 9L cells and, compared to untreated control cells, caused no perturbation of cell cycle kinetics. alpha-Difluoromethylornithine-induced depletion of intracellular polyamine levels appears to have caused the observed sensitization of 9L cells to 1,3-bis(2-chloroethyl)-1-nitrosourea. Restoration of intracellular polyamine levels by the addition of exogenous putrescine to treated 9L cells reversed this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6788362

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Effects of DFMO-induced polyamine depletion on human tumor cell sensitivity to antineoplastic DNA-crosslinking drugs.

Authors:  J Seidenfeld; K A Komar; M F Naujokas; A L Block
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Molecular dynamics of spermine-DNA interactions: sequence specificity and DNA bending for a simple ligand.

Authors:  B G Feuerstein; N Pattabiraman; L J Marton
Journal:  Nucleic Acids Res       Date:  1989-09-12       Impact factor: 16.971

3.  Variations in amplification and expression of the ornithine decarboxylase gene in human breast cancer cells.

Authors:  T Thomas; D T Kiang; O A Jänne; T J Thomas
Journal:  Breast Cancer Res Treat       Date:  1991-11       Impact factor: 4.872

Review 4.  The chemotherapeutic potential of polyamine antimetabolites.

Authors:  A N Kingsnorth
Journal:  Ann R Coll Surg Engl       Date:  1986-03       Impact factor: 1.891

5.  Phase I study of combined alpha interferon, alpha difluoromethylornithine (DFMO), and doxorubicin in advanced malignancy.

Authors:  V Ganju; J H Edmonson; J C Buckner
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

6.  Polyamines in clinical disorders.

Authors:  D F Tierney; L J Marton; A D Hacker; N Lowe
Journal:  West J Med       Date:  1985-01

7.  CNS toxicity and CSF pharmacokinetics of intraventricular DFMO and MGBG in beagle dogs.

Authors:  V A Levin; D Byrd; J Campbell; R L Davis; J K Borcich
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

8.  Putrescine metabolism in human brain tumors.

Authors:  S S Goldman; N D Volkow; J Brodie; E S Flamm
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

9.  Polyamine biosynthesis is required for the maintenance of peripheral blood cell elements in the rat.

Authors:  G D Luk; S J Sharkis; M D Abeloff; P P McCann; A Sjoerdsma; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

10.  Effects of alpha-difluoromethylornithine on initiation and promotion of urinary bladder carcinogenesis in a heterotopically transplanted rat urinary bladder.

Authors:  K Rinsho; K Uchida; S Samma; R Oyasu
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.